204 results
Page 3 of 11
8-K
EX-2.1
3cbaov9qj tpl
27 Oct 20
Exact Sciences to Acquire Thrive, Becoming a Leader In Blood-based, Multi-cancer Screening
7:04am
8-K
EX-99
ski8ej
27 Oct 20
Exact Sciences Announces Third Quarter 2020 Results
7:03am
8-K
EX-10.1
kwev hl6nzr
7 Oct 20
Entry into a Material Definitive Agreement
6:02am
8-K
EX-99
pmgj4tbup bgw
30 Jul 20
Exact Sciences Announces Second Quarter 2020 Results
6:46pm
11-K
dpgtl2k4x1q6c
29 Jun 20
Annual report of employee stock purchases
12:00am
S-3ASR
EX-4.7
zx3t3swgoafcr
1 Jun 20
Automatic shelf registration
4:10pm
DEFA14A
b8wi3f07nc5
29 Apr 20
Additional proxy soliciting materials
4:08pm
8-K
9yd2ksl9
21 Apr 20
Results of Operations and Financial Condition
4:32pm
8-K
EX-99.1
v0g62y6c7j1olpl
27 Feb 20
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
5:09pm
8-K
EX-99.2
0gw7yn
27 Feb 20
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
5:09pm
8-K
EX-1.1
6lcfiutr4ocg wfsxwq
27 Feb 20
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
5:09pm
8-K
EX-4.2
3sfym54w wn0x
27 Feb 20
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
5:09pm
424B5
vbsnz 1c79
26 Feb 20
Prospectus supplement for primary offering
4:25pm